Injectable Drug Delivery Resources

1. Design Success Combined With Expertise In Testing And Raw Material Selection

   Learn more about improvements and optimized benefits across the packaging attributes required for performance, quality, and safety of the packaging and delivery of lyophilized drug products.

2. A Practical Packaging Components Checklist For Emerging Biotechs 6/20/2024

   A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.

3. Cut Through Complexity, Gain Speed, And Get Your Drug To Patients ASAP

   Discover top challenges that emerging biologics face, packaging containment offerings and services that help mitigate risks, and ways to reduce obstacles that slow development.

4. Evaluating The Impact Of Sterilization Methods On Stopper Performances 3/11/2022

   Three studies focus on a product designed to address unmet needs in subcutaneous drug therapies for chronic diseases, including sterilization methods and a Human Factors evaluation.

5. Gliding Towards De-Risked Combination Product Development 3/11/2022

   Learn about the critical role plunger stoppers play in determining a combination drug product's exposure to extractables and leachables.

6. Data-Driven Innovation Is Drug Delivery's Next Evolution 7/23/2025

   To mitigate inherent risks like inconsistent dosing, user error, and low adoption due to complex usage procedures, technological innovation in delivery devices is best guided by lessons from the past, including user feedback and follow-on learnings from market data.

7. How To Protect A Modern Silicone Oil-Sensitive Biologic Drug For Self-Injection Of 2.25mL 4/25/2023

   A customer experienced expensive project delays when they selected their “tried and tested” large volume, glass syringe system to package a drug to be used in an auto-injector for self-administration.

8. Is Your Combination Product Drug-Led Or Device-Led? 11/30/2022

   The $118 billion combination-product market is projected to increase at a CAGR of 8.8%. This article answers the question: “Is this actually a combination product? What do we need to do if it is?”

9. Is The Autoinjector Dead? The Future Of Patient-Centered Drug Delivery 9/1/2025

   Autoinjectors revolutionized drug delivery, but innovation is shifting toward oral, wearable, and alternative platforms. Future focus emphasizes patient experience, sustainability, and broader drug delivery toolkits beyond the autoinjector.

10. A Smooth Transition To USP <382> With Established Expertise 3/16/2026

    A new regulatory chapter requires holistic, real‑world testing of injectable systems, mandating full‑system validation with actual drug products and prioritizing patient‑centric performance and safety.